Black Diamond Therapeutics, Inc. - 8-K Filing
Black Diamond Therapeutics held its 2026 Annual Meeting of Stockholders on June 26, 2026. Shareholders elected Shannon Campbell and Kapil Dhingra to the Board with votes in favor totaling 19,251,021 and 13,966,232 respectively; ratified PwC as auditors (44,421,545 for); approved executive compensation (35,071,684 for); and voted to hold future advisory votes on executive pay annually (30,446,520 in favor of 1-year frequency). (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $BDTX